Citation Impact
Citing Papers
Matrix Protein CCN1 Is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis
2009 Standout
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
Evolution of the Cancer Stem Cell Model
2014 Standout
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
2016
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
2020
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
The inhibitors of apoptosis (IAPs) as cancer targets
2007
Combination cancer immunotherapy and new immunomodulatory targets
2015
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Cancer drug resistance: an evolving paradigm
2013 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Cancer stem cells revisited
2017 Standout
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Antibody therapy of cancer
2012 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
2015 StandoutNobel
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The cancer stem cell: premises, promises and challenges
2011 Standout
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
2009
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
2008
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Crypt stem cells as the cells-of-origin of intestinal cancer
2008 StandoutNature
Identification of stem cells in small intestine and colon by marker gene Lgr5
2007 StandoutNature
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
To kill a tumor cell: the potential of proapoptotic receptor agonists
2008
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
2017
TNF‐related apoptosis‐inducing ligand as a therapeutic agent in autoimmunity and cancer
2006
Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
2009
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy.
2009
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
2010
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
2015
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
2009 Standout
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5
2008
Works of Vui Pham being referenced
Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy
2012
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
2018
Elimination of Hepatic Metastases of Colon Cancer Cells via p53-Independent Cross-Talk between Irinotecan and Apo2 Ligand/TRAIL
2004
Resistance of Cancers to Immunologic Cytotoxicity and Adoptive Immunotherapy via X-Linked Inhibitor of Apoptosis Protein Expression and Coexisting Defects in Mitochondrial Death Signaling
2006